PDS Biotechnology Corporation announces the initial closing of up to $22.3 million PIPE financing, raising $11.3 million. The round was led by Nant Capital with participation from current investors.
Amount Raised
$11.3 Million
Round Type
Post-IPO Equity
PrincetonBiotechnologyHealth CareTherapeuticsInvestors
Description
PDS Biotechnology Corporation has completed the initial closing of its Private Investment in Public Equity transaction. The company raised approximately $11.3 million to repay outstanding indebtedness and for general corporate purposes. The financing includes participants like Nant Capital, LLC.
Quick answer
PDS Biotech raised $11.3 Million in a Post-IPO Equity round, dated September 14, 2026. Investors: Nant Capital, LLC. PDS Biotech is based in Princeton, New Jersey, United States.
- How much did PDS Biotech raise?
- PDS Biotech raised $11.3 Million in a Post-IPO Equity round on September 14, 2026.
- Who invested in PDS Biotech?
- Nant Capital, LLC is named as investors in this round.
- What does PDS Biotech do?
- PDS Biotech is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapies based on the Versamune® platform, a T-cell activating technology, designed to harness the power of..
- Where is PDS Biotech based and how big is it?
- PDS Biotech is based in Princeton, New Jersey, United States. Fundz records about 21 employees.
- Who are the decision-makers at PDS Biotech?
- Fundz holds 2 contacts at PDS Biotech, including the Vice President, Technical Operations & Manufacturing. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as PDS Biotech that raised within 45 days of this round, from Fundz verified event records.
- StimCardio raised $30M (Series A) on October 29, 2026.
- Sonocare Lab raised an undisclosed amount (Seed) on October 29, 2026.
- Tivic raised $85M (Series B) on October 27, 2026.
- VolitionRx raised $2.4M (Convertible Note) on October 27, 2026.
- Quanta Therapeutics raised an undisclosed amount (Series D) on October 24, 2026.
- Pathos AI raised $237M (Series E) on October 23, 2026.
Who to call at PDS Biotech, and when
A new round usually means PDS Biotech is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day PDS Biotech raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at PDS Biotech, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at PDS Biotech. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment PDS Biotech raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
PDS Biotech raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.